Cairo – Mubasher: Nile Pharmaceuticals and Chemical Industries (Nile Pharma) is expecting to achieve a net-profit-before-tax of EGP 153.7 million in the fiscal year 2020/2021.
Revenue is expected to reach EGP 1.1 billion in FY20/21, compared to EGP 740 million in FY19/20, according to a bourse statement released on Thursday.
It is worth highlighting that Nile Pharma reported a net profit of EGP 34.9 million in the six-month period ended 31 December 2019, against net losses of EGP 5.15 million in the year-ago period.
